Lexitas Pharma Services and Ocusun Enroll First Patient in a Pilot Study for an Upcoming Phase III Clinical Trial Evaluating Investigational Eye Drop for Age-Related Cataract
Multicenter U.S. study advances a potential new option for a condition affecting millions DURHAM, N.C. and GUANGZHOU, China , July 14, 2026 /PRNewswire/ -- Lexitas Pharma Services, a leading full-service ophthalmology clinical research organization (CRO), and Ocusun, a high-tech...
Multicenter U.S. study advances a potential new option for a condition affecting millions DURHAM, N.C. and GUANGZHOU, China , July 14, 2026 /PRNewswire/ -- Lexitas Pharma Services, a leading full-service ophthalmology clinical research organization (CRO), and Ocusun, a high-tech...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.